Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Differential expression profiling of lncRNAs related to Epstein-Barr virus infection in the epithelial cells.

Zhang J, Zhang S, Zuo L, Yue W, Li S, Xin S, Liu L, Lu J.

J Med Virol. 2019 Jun 14. doi: 10.1002/jmv.25516. [Epub ahead of print]

PMID:
31199512
2.

SNHG8 is identified as a key regulator of epstein-barr virus(EBV)-associated gastric cancer by an integrative analysis of lncRNA and mRNA expression.

Huang T, Ji Y, Hu D, Chen B, Zhang H, Li C, Chen G, Luo X, Zheng XW, Lin X.

Oncotarget. 2016 Dec 6;7(49):80990-81002. doi: 10.18632/oncotarget.13167.

3.

NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.

Verhoeven RJ, Tong S, Zhang G, Zong J, Chen Y, Jin DY, Chen MR, Pan J, Chen H.

J Virol. 2016 Jun 24;90(14):6475-88. doi: 10.1128/JVI.00613-16. Print 2016 Jul 15.

4.

Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region.

Marquitz AR, Mathur A, Edwards RH, Raab-Traub N.

J Virol. 2015 Nov;89(22):11256-68. doi: 10.1128/JVI.01492-15. Epub 2015 Aug 26.

5.

Genome-wide analyses of long noncoding RNA expression profiles correlated with radioresistance in nasopharyngeal carcinoma via next-generation deep sequencing.

Li G, Liu Y, Liu C, Su Z, Ren S, Wang Y, Deng T, Huang D, Tian Y, Qiu Y.

BMC Cancer. 2016 Sep 6;16:719. doi: 10.1186/s12885-016-2755-6.

6.

Epstein-Barr virus infection and nasopharyngeal carcinoma.

Tsao SW, Tsang CM, Lo KW.

Philos Trans R Soc Lond B Biol Sci. 2017 Oct 19;372(1732). pii: 20160270. doi: 10.1098/rstb.2016.0270. Review.

7.

Analysis of Epstein-Barr Virus Genomes and Expression Profiles in Gastric Adenocarcinoma.

Borozan I, Zapatka M, Frappier L, Ferretti V.

J Virol. 2018 Jan 2;92(2). pii: e01239-17. doi: 10.1128/JVI.01239-17. Print 2018 Jan 15. Erratum in: J Virol. 2018 Apr 27;92 (10 ):.

8.

The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.

Tsang CM, Tsao SW.

Virol Sin. 2015 Apr;30(2):107-21. doi: 10.1007/s12250-015-3592-5. Epub 2015 Apr 21. Review.

PMID:
25910483
9.

EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.

Zhang J, Jia L, Tsang CM, Tsao SW.

Adv Exp Med Biol. 2017;1018:75-90. doi: 10.1007/978-981-10-5765-6_6. Review.

PMID:
29052133
10.

Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.

Tu C, Zeng Z, Qi P, Li X, Yu Z, Guo C, Xiong F, Xiang B, Zhou M, Gong Z, Liao Q, Yu J, He Y, Zhang W, Li X, Li Y, Li G, Xiong W.

J Virol. 2017 Aug 10;91(17). pii: e00301-17. doi: 10.1128/JVI.00301-17. Print 2017 Sep 1.

11.

Analysis of Differential Expressions of Long Non-coding RNAs in Nasopharyngeal Carcinoma Using Next-generation Deep Sequencing.

Li XX, Liang XJ, Zhou LY, Liu RJ, Bi W, Zhang S, Li SS, Yang WH, Chen ZC, Yang XM, Zhang PF.

J Cancer. 2018 Apr 30;9(11):1943-1950. doi: 10.7150/jca.23481. eCollection 2018.

12.

Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs.

Wong AM, Kong KL, Tsang JW, Kwong DL, Guan XY.

Cancer. 2012 Feb 1;118(3):698-710. doi: 10.1002/cncr.26309. Epub 2011 Jun 30.

13.

Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.

Zhang Y, Wang H, Liu Y, Wang C, Wang J, Long C, Guo W, Sun X.

Biomed Pharmacother. 2018 Jun;102:1003-1014. doi: 10.1016/j.biopha.2018.03.114. Epub 2018 Apr 5.

PMID:
29710517
14.

Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1.

Song Y, Li X, Zeng Z, Li Q, Gong Z, Liao Q, Li X, Chen P, Xiang B, Zhang W, Xiong F, Zhou Y, Zhou M, Ma J, Li Y, Chen X, Li G, Xiong W.

Oncotarget. 2016 Jun 14;7(24):36783-36799. doi: 10.18632/oncotarget.9170.

15.

Emerging roles of small Epstein-Barr virus derived non-coding RNAs in epithelial malignancy.

Lung RW, Tong JH, To KF.

Int J Mol Sci. 2013 Aug 23;14(9):17378-409. doi: 10.3390/ijms140917378. Review.

16.

Knockdown of the lncRNA SNHG8 inhibits cell growth in Epstein-Barr virus-associated gastric carcinoma.

Liu J, Yang C, Gu Y, Li C, Zhang H, Zhang W, Wang X, Wu N, Zheng C.

Cell Mol Biol Lett. 2018 Apr 27;23:17. doi: 10.1186/s11658-018-0070-8. eCollection 2018.

17.

Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.

Ramayanti O, Juwana H, Verkuijlen SA, Adham M, Pegtel MD, Greijer AE, Middeldorp JM.

Int J Cancer. 2017 Jan 1;140(1):149-162. doi: 10.1002/ijc.30418. Epub 2016 Sep 23.

18.

Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103.

He B, Li W, Wu Y, Wei F, Gong Z, Bo H, Wang Y, Li X, Xiang B, Guo C, Liao Q, Chen P, Zu X, Zhou M, Ma J, Li X, Li Y, Li G, Xiong W, Zeng Z.

Cell Death Dis. 2016 Sep 1;7(9):e2353. doi: 10.1038/cddis.2016.253.

20.

Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.

Zhong BL, Zong YS, Lin SX, Zhang M, Liang YJ.

Ai Zheng. 2006 Feb;25(2):136-42.

PMID:
16480574

Supplemental Content

Support Center